Apyx Medical Corporation
APYX
$1.99
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.96% | 10.33% | 1.59% | 28.26% | 13.46% |
| Total Depreciation and Amortization | -4.35% | -2.82% | -1.39% | -7.69% | -0.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.21% | -63.10% | 43.39% | -1.17% | -1.58% |
| Change in Net Operating Assets | -50.13% | 758.12% | 68.12% | -276.57% | 322.22% |
| Cash from Operations | -75.64% | 76.10% | 33.85% | -2.56% | 31.73% |
| Capital Expenditure | -381.82% | 77.55% | -60.13% | 47.06% | -725.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -381.82% | 77.55% | -60.13% | 47.06% | -725.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 112.77% | -- | -- | -- |
| Cash from Financing | 0.00% | -99.63% | 135,300.00% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -11,950.00% | -98.67% | 323.88% | -452.63% | 72.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.25% | -119.58% | 179.91% | -1.32% | 27.72% |